75J.F LEVELJUMP HEALTHCARE CORP

Healthcare Biotechnology Frankfurt Exchange
0.0245 EUR
Close of Nov 11, 2026
0.0180 0.0410
Market cap
EUR 2.72M
P/E
-
P/B
1.51x
ROE
-55.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 75J.F undervalued?

Graham number

The Graham number of LEVELJUMP HEALTHCARE CORP cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LEVELJUMP HEALTHCARE CORP fundamental analysis

No fundamental analysis for LEVELJUMP HEALTHCARE CORP yet.

LEVELJUMP HEALTHCARE CORP stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LEVELJUMP HEALTHCARE CORP

Leveljump Healthcare Corp., together with its subsidiaries, provides radiology services in Canada. The company offers direct patient images and teleradiology services; and telehealth services for doctor-to-doctor collaboration and diagnosis. It also owns and operates Canadian Teleradiology Services for emergency room care for hospitals. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.

Full company profile